Physician

Brent M. Boyce, M.D.

According to 2025 Medicare claims, Brent Boyce, M.D. (NPI: 1417944786) practices dermatology in the Bay City, MI market, with the plurality of this provider's patient population coming from Bay, MI. This provider's primary affiliated billing organization is BRENT M BOYCE MD PC (NPI: 1982736054; TIN: 20-0060755) and primary practice location at 48706-2554. Boyce is affiliated with the POM ACO (ACO ID: A1297), McLaren High Performance Network, LLC (ACO ID: A3317), Mosaic ACO (ACO ID: A5033), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Boyce's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,531 traditional Medicare patients, billed 7,955 HCPCS/CPT codes, and received $311,713 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 3,604 prescription claims across 1,368 beneficiaries totaling $8,301,487 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 303 records totaling $307,042. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,638,266 to $8,301,487. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,620	6,462	$234,506
2016	1,612	6,163	$216,996
2017	1,605	6,854	$236,131
2018	1,477	6,232	$222,980
2019	1,556	6,368	$237,899
2020	1,220	4,657	$176,965
2021	1,358	5,208	$209,767
2022	1,455	5,737	$250,330
2023	1,453	6,991	$296,269
2024	1,531	7,955	$311,713

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,166	3,154	$1,638,266
2016	1,242	3,351	$2,015,084
2017	1,139	3,019	$2,227,770
2018	1,023	2,689	$2,653,549
2019	1,100	3,016	$3,374,771
2020	1,189	3,385	$4,016,454
2021	1,324	3,554	$4,811,810
2022	1,277	3,404	$5,805,786
2023	1,238	3,308	$7,001,456
2024	1,368	3,604	$8,301,487

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	297	328	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	881	1,016	$60
17000	Destruction of precancer skin growth, 1 growth	586	672	$38
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	232	245	$37
17003	Destruction of precancer skin growth, 2-14 growths	421	1,993	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	140	10,976	$2,922,624
Humira(Cf) Pen	Adalimumab	113	3,310	$1,098,057
Tremfya	Guselkumab	64	3,560	$860,072
Dupixent Pen	Dupilumab	156	4,512	$626,470
Stelara	Ustekinumab	16	1,232	$422,867

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	254	$32,038	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	49	$275,004	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brent M. Boyce, M.D.?

Tedicare shows public-source Medicare data for Brent M. Boyce, M.D. (NPI 1417944786), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brent M. Boyce, M.D. have ACO affiliation data?

Brent M. Boyce, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), Mosaic ACO (MSSP, ACO ID A5033), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Brent M. Boyce, M.D.?

Brent M. Boyce, M.D. is linked to BRENT M BOYCE MD PC (billing NPI 1982736054) in the available physician profile data.

Does Brent M. Boyce, M.D. have Open Payments data?

Brent M. Boyce, M.D. has 303 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.